Biovitrum Company Profile

Aggregated data from the web about Biovitrum

Company Name	Biovitrum
Website	sobi.com
Snippet	Swedish Orphan Biovitrum AB is an international biopharmaceutical company dedicated to treatments in the areas of haematology, immunology and specialty care, based in Stockholm, Sweden. Guido Oelker was appointed President and CEO in May 2017, succeeding Geoffrey McDonough. Oelkers had previously been CEO of BSN medical [de].[1][2]
Type	Public
Parent	Investor AB (40%)
Founded	2010
Revenue	SEK 14.248 billion (2019)
Website	sobi.com
Industry	Pharmaceutical
Products	Treatments in the areas of haematology, immunology and specialty care
Traded as	Nasdaq Stockholm: SOBI
Key people	Guido Oelker (President and CEO)
Headquarters	Stockholm, Sweden
Number of employees	1355

Biovitrum is part of the Sweden company list

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.